1996
1995total
revenues
2,865,835
4,748,935net
income
loss
112,165
1,287,115weighted
averagenumber
shares
outstanding
4,722,709
4,872,481net
income
loss
common
equivalent
share
0.02
0.26note
total
revenues
income
decreased
1996
partial
closure
daxor
facilities
30
1996
new
york
appellate
court
unanimous
5-0
decision
ordered
reopening
daxor
sperm
blood
banking
facilities
daxor
currently
rico
antitrust
suit
pending
new
york
blood
center
certain
new
york
state
health
department
officials
